Qube Research & Technologies Ltd - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 56 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2021$30,000
-63.9%
32,413
-81.0%
0.00%
-100.0%
Q4 2020$83,000
-79.6%
170,498
-67.2%
0.00%
-83.3%
Q3 2020$407,000
+784.8%
519,063
+508.6%
0.01%
+500.0%
Q2 2020$46,00085,2920.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
Firestone Capital Management 5,200$4,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders